Cargando…

Erratum to: Adding Prandial Insulin to Basal Insulin Plus Oral Antidiabetic Drugs in Chinese Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Single-Arm Study

Detalles Bibliográficos
Autores principales: Jin, Yujing, Sun, Xiaowei, Zhao, Xichen, Zhu, Tiehong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446385/
https://www.ncbi.nlm.nih.gov/pubmed/28401453
http://dx.doi.org/10.1007/s13300-017-0260-9
_version_ 1783239057695834112
author Jin, Yujing
Sun, Xiaowei
Zhao, Xichen
Zhu, Tiehong
author_facet Jin, Yujing
Sun, Xiaowei
Zhao, Xichen
Zhu, Tiehong
author_sort Jin, Yujing
collection PubMed
description
format Online
Article
Text
id pubmed-5446385
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-54463852017-06-12 Erratum to: Adding Prandial Insulin to Basal Insulin Plus Oral Antidiabetic Drugs in Chinese Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Single-Arm Study Jin, Yujing Sun, Xiaowei Zhao, Xichen Zhu, Tiehong Diabetes Ther Erratum Springer Healthcare 2017-04-11 2017-06 /pmc/articles/PMC5446385/ /pubmed/28401453 http://dx.doi.org/10.1007/s13300-017-0260-9 Text en © The Author(s) 2017 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Erratum
Jin, Yujing
Sun, Xiaowei
Zhao, Xichen
Zhu, Tiehong
Erratum to: Adding Prandial Insulin to Basal Insulin Plus Oral Antidiabetic Drugs in Chinese Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Single-Arm Study
title Erratum to: Adding Prandial Insulin to Basal Insulin Plus Oral Antidiabetic Drugs in Chinese Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Single-Arm Study
title_full Erratum to: Adding Prandial Insulin to Basal Insulin Plus Oral Antidiabetic Drugs in Chinese Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Single-Arm Study
title_fullStr Erratum to: Adding Prandial Insulin to Basal Insulin Plus Oral Antidiabetic Drugs in Chinese Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Single-Arm Study
title_full_unstemmed Erratum to: Adding Prandial Insulin to Basal Insulin Plus Oral Antidiabetic Drugs in Chinese Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Single-Arm Study
title_short Erratum to: Adding Prandial Insulin to Basal Insulin Plus Oral Antidiabetic Drugs in Chinese Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Single-Arm Study
title_sort erratum to: adding prandial insulin to basal insulin plus oral antidiabetic drugs in chinese patients with poorly controlled type 2 diabetes mellitus: an open-label, single-arm study
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446385/
https://www.ncbi.nlm.nih.gov/pubmed/28401453
http://dx.doi.org/10.1007/s13300-017-0260-9
work_keys_str_mv AT jinyujing erratumtoaddingprandialinsulintobasalinsulinplusoralantidiabeticdrugsinchinesepatientswithpoorlycontrolledtype2diabetesmellitusanopenlabelsinglearmstudy
AT sunxiaowei erratumtoaddingprandialinsulintobasalinsulinplusoralantidiabeticdrugsinchinesepatientswithpoorlycontrolledtype2diabetesmellitusanopenlabelsinglearmstudy
AT zhaoxichen erratumtoaddingprandialinsulintobasalinsulinplusoralantidiabeticdrugsinchinesepatientswithpoorlycontrolledtype2diabetesmellitusanopenlabelsinglearmstudy
AT zhutiehong erratumtoaddingprandialinsulintobasalinsulinplusoralantidiabeticdrugsinchinesepatientswithpoorlycontrolledtype2diabetesmellitusanopenlabelsinglearmstudy